Teva Announces Launch of a Generic Version of Letairis® (ambrisentan) Tablets in the United States

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. DELL
3. ROIV
4. ANET
5. NKE
6. PANW
7. CL
8. SNDK
9. TAP
10. EAT

Go back to Teva Announces Launch of a Generic Version of Letairis® (ambrisentan) Tablets in the United States
TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 36.36 -0.26 (0.71%)
Previous Close $36.62    52 Week High $66.55 
Open $36.40    52 Week Low $37.82 
Day High $36.93    P/E N/A 
Day Low $36.13    EPS $0.00 
Volume 7,402,525       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 36.36 -0.26 (0.71%)
Previous Close $36.62    52 Week High $66.55 
Open $36.40    52 Week Low $37.82 
Day High $36.93    P/E N/A 
Day Low $36.13    EPS $0.00 
Volume 7,402,525